Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece: The ADMIRE Study

NCT05683912 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT05683912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05683912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece: The ADMIRE Study
Lead sponsor
University of Athens
Phase
Observational
Overall status
Completed
Start date
September 1, 2019
Completion date
December 15, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema